Accordingly, we found that the expressions of SPRR1B and SPRR2D in multiple tumor data sets were higher in tumor tissues than in normal tissues (72 vs. 16 and 62 vs. 22, respectively), and the data sets with high expression in lung cancer were significantly more than those of other types of cancer. Here, SPRR2D is linked to lung cancer.